Hemodialysis And Peritoneal Dialysis Market Size, Share & Trends Analysis Report By Type (Hemodialysis, Peritoneal Dialysis), By Product (Device, Consumables, Service), By End Use, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global hemodialysis and peritoneal dialysis market size was valued at USD 88.16 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.61% from 2022 to 2030. Rising incidence of Acute Kidney Injury (AKI), shortage of organ donors, risks associated with transplants, technological advancements, and initiatives by the leading players to introduce advanced products and services are a few factors driving the demand for hemodialysis and peritoneal dialysis, thereby propelling the market growth. In addition, the outbreak of the COVID-19 pandemic has resulted in a significant demand for dialysis across the world. Owing to this, the market has witnessed regulatory support from various government authorities and a rise in financial incentives. These factors are expected to contribute to the positive growth of the market during the forecast period.

The COVID-19 pandemic had considerably impacted the dialysis care market globally. The pandemic had led to a sudden increase in demand for dialysis devices and consumables due to high hospitalization rates. For instance, as per the CDC statistics of 2021, CKD affected an estimated 37 million U.S. individuals, i.e., 1 in 7 U.S. adults. This was mainly owing to the higher prevalence of comorbid conditions, such as CKD, diabetes, and hypertension. In addition, the pandemic led to major interruptions in the supply chain, which created challenges for manufacturers in keeping up with supply. Moreover, rising medical needs deriving from the geriatric populace, stronger demand for innovative products and therapies, and advancements in medical technologies are expected to further add to the market growth post-COVID-19. In addition, rising efforts by public and private organizations to encourage home HD/PD can further create profitable opportunities for the market post-COVID-19.

The rising incidence of AKIs is a key factor expected to drive the demand for hemodialysis and peritoneal dialysis. For instance, the National Kidney Foundation, Inc. projected that more than one in seven adults are affected by kidney disease. The following figure depicts the percentage of U.S. adults aged 18 years or older and gender-wise affected by Chronic Kidney Disease (CKD). According to the CDC, more than approximately 37 million people are estimated to have CKD. Furthermore, according to the same source, CKD is more common in people over the age of 65 years and can lead to dialysis.

Moreover, in the past few years, the requirement for dialysis has increased. For instance, according to the National Kidney Foundation in 2018, 785,883 U.S. residents faced kidney failure, of which, 554,038 received dialysis. Likewise, according to data published by the FDA, about 10,000 children in the U.S. develop acute AKI. These children have a survival rate of around 38% to 43%. The death rate for neonates with AKI is around 60%. Fluid overload is prevalent in critically ill neonates and children, especially after procedures such as cardiac surgery. Such factors are likely to drive the demand for neonatal hemodialysis, thereby propelling market growth.

The U.S. dominated the North American market with a revenue share of over 90.0% in 2021. The increasing prevalence of chronic kidney disease and healthcare spending by Medicare are contributing to the growth of the market in the country. As per the National Kidney Foundation, in 2019, more than 500,000 patients have undergone dialysis and more than 200,000 people are living with a kidney transplant. Moreover, Medicare cost for people with all stages of CKD in 2017 was around USD 120 billion. In 2017, Medicare spent USD 84 billion on people with CKD and USD 36 billion on people with End-Stage Kidney Disease (ESKD).

Furthermore, the demand for home care dialysis services has increased over the years and is expected to increase further. Patients suffering from acute and chronic kidney diseases are treated at home or at outpatient facilities. Hence, the demand for renal home therapies has increased. Moreover, according to the NCBI, as of 2017, 10.8% of U.S. residents are dialyzed at home, which is a 30% increase in home dialysis over the past decade. In 2019, Advancing Kidney Health Initiative proposed to increase the number of patients with renal failure to be treated at home by hemodialysis or peritoneal dialysis. Additionally, CMS proposed a goal where 80% of dialysis patients are to be treated with the help of a home dialysis setting. With such initiatives undertaken by governments and organizations, the demand for home care dialysis services is expected to increase over the forecast period.

Type Insights

In 2021, the hemodialysis segment dominated the market with a revenue share of over 85.0% and is expected to expand at the highest CAGR during the forecast period. In addition, the hemodialysis segment is further fragmented into conventional, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis is further sub-segmented into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Ambulatory Peritoneal Dialysis (APD). The rising number of ESRD patients, a surge in the geriatric population suffering from kidney diseases, and the rising prevalence of diabetes and hypertension are significant factors driving the segment. According to World Population Ageing 2020 report, there were an estimated 727 million people aged 65 years or over worldwide. The portion of the populace is projected to more than double by 2050, reaching over 1.5 billion persons. An aging population and a rising risk of CKD are projected to significantly boost the segment growth.

Hemodialysis involves the use of a hemodialyzer to remove extra and waste fluids and chemicals from the body. The blood comes into contact with dialysate as it passes through the filter, which is similar to bodily fluid except for the presence of impurities. This is a relatively complicated type of dialysis with a rigorous treatment framework and restricted flexibility in terms of patients' time, mobility, and transportation. In addition, it entails the establishment and maintenance of vascular access, such as a dialysis catheter or the formation of an AV fistula or graft in either the arm or the groin to access the high blood flows required for dialysis.

Product Insights

In 2021, the service segment dominated the market with a share of over 55.0%. This can be attributed to an increase in the number of dialysis service providers and an increase in the prevalence of ESRD. In addition, several key dialysis service providers are looking to expand their service offerings by opening and purchasing new dialysis centers throughout the world, which is expected to boost segment growth. Technological advancements and initiatives undertaken by various manufacturers are expected to further boost market growth. For instance, in February 2021, DaVita incorporated a secure telehealth technology, DaVita Care Connect, into its home dialysis sector. It was one of the many connective technologies in its suite of services aimed at improving treatment and outcomes for patients who choose to treat themselves at home.

The consumables segment is expected to expand at the highest CAGR of 6.8% during the forecast period. Significant investments from the governments to enhance patient safety, patient-centered care, and efficacy are expected to support the segment growth over the forecast period. Companies are creating catheters made of sophisticated materials resistant to chemicals such as peroxides, iodine, and alcohol. This can help extend the life of catheters and lower the chances of malfunctioning. Furthermore, the demand for antimicrobial-coated catheters is increasing, which minimizes the rate of bloodstream infections. Similarly, new dialyzer manufacturing technologies, such as improved surface contact and cutoff membrane dialyzers for greater diffusion, have a beneficial impact on the growth of the consumable segment. The consumables market has been further segmented into bloodlines, concentrates, catheters, and others.

End-use Insights

In 2021, the hospital-based segment dominated the market with a share of over 80.0%. The segment is likely to maintain its lead in the coming years because of the significant availability of highly qualified and experienced healthcare personnel in the hospitals. The presence of a professional and experienced renal care team ensures optimal treatment and enhanced dialysis results in healthcare settings such as dialysis centers and hospitals. In addition, the growing focus of players on building independent dialysis centers and the high adoption of patients for the treatment in in-center dialysis are some of the factors projected to drive the segment. Moreover, companies are focusing on the development of customized hemodialysis machines with a variety of interventions. This is likely to have an influence on the end-user experience. 

The home-based segment is expected to expand at the highest CAGR of 7.6% during the forecast period. Home dialysis has various advantages, including increased quality of life, lower travel costs, flexibility, and easier patient mobility, which will enhance its adoption rate in the next years. Similarly, an increase in the choice for home dialysis therapy among the older population suffering from various renal dysfunctions will further boost the segment revenue. The development of smaller dialysis machines that can be put on a nightstand as well as easier blood tubing and dialyzer connections have resulted in a growing number of patients preferring this mode of dialysis to maintain their independence and high functional status.

Regional Insights

North America dominated the market with the largest revenue share of over 35.0% in 2021. The presence of key participants, significant investments by governments for the development of innovative medical devices, and the presence of a favorable reimbursement scenario are supplementing the growth of the market in the region. Due to the rising incidence of kidney failures and Chronic Kidney Diseases (CKD), there is increasing demand for dialysis. Increasing healthcare spending, government initiatives, and high disposable income are a few other factors contributing to the market growth. 

The Asia Pacific region is estimated to register the highest CAGR of 7.6% over the forecast period. Over the forecast period, rising incidences of kidney failure, the growing geriatric population, and the augmented development of advanced products are expected to support market growth. Furthermore, as per the IDF, in South East Asia, around 88 million adults are living with diabetes and the number is expected to increase to 153 million by 2045. Moreover, increasing healthcare spending, rising government initiatives, awareness campaigns regarding CKD, technologically enhanced products, and the presence of newly-established state-of-the-art healthcare facilities in the region are a few other factors contributing to market growth.

Key Companies & Market Share Insights

The key market players are focusing on the launch of innovative products, growth strategies, and technological advancements. For instance, in October 2019, Fresenius Medical Care received a breakthrough device designation by the U.S. FDA for its new hemodialysis machine that aims to stop blood clotting without the use of any medication. Additionally, few key players are introducing technologically advanced products to achieve a competitive advantage in the industry. Advancements in the market are anticipated to boost the market growth over the forecast period. For instance, in December 2020, Medtronic launched a dialysis machine for neonatal and pediatrics in the U.S. This launch helped the company to increase its market share in the renal segment.

Some prominent players in the global hemodialysis and peritoneal dialysis market include:

• Baxter

• B. Braun Melsungen AG

• Fresenius Medical Care AG

• Medtronic

• Asahi Kasei Medical Co., Ltd.

• Nipro Corp.

• DaVita

• BD

• Nikkiso Co., Ltd.

• Cantel Medical

Hemodialysis And Peritoneal Dialysis Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global hemodialysis and peritoneal dialysis market report based on type, product, end use, and region:

• Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Hemodialysis

    • Conventional hemodialysis

    • Short daily hemodialysis

    • Nocturnal hemodialysis

  • Peritoneal dialysis

    • Continuous Ambulatory Peritoneal Dialysis (CAPD)

    • Automated Peritoneal Dialysis (APD)

• Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Device

    • Machine

    • Dialyzer

    • Water treatment system

    • Others

  • Consumables

    • Bloodline

    • Concentrates

    • Catheters

    • Others

  • Services

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Home-based

  • Hospital-based

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE